Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study.

Sloan SE, Szretter KJ, Sundaresh B, Narayan KM, Smith P, Skurnik D, Bedard S, Trevejo JM, Oldach D, Shriver Z.

Antiviral Res. 2020 Mar 6:104763. doi: 10.1016/j.antiviral.2020.104763. [Epub ahead of print]

2.

Genetic effects on the commensal microbiota in inflammatory bowel disease patients.

Aschard H, Laville V, Tchetgen ET, Knights D, Imhann F, Seksik P, Zaitlen N, Silverberg MS, Cosnes J, Weersma RK, Xavier R, Beaugerie L, Skurnik D, Sokol H.

PLoS Genet. 2019 Mar 8;15(3):e1008018. doi: 10.1371/journal.pgen.1008018. eCollection 2019 Mar.

3.

Impact of Implementing National Guidelines on Antibiotic Prescriptions for Acute Respiratory Tract Infections in Pediatric Emergency Departments: An Interrupted Time Series Analysis.

Ouldali N, Bellêttre X, Milcent K, Guedj R, de Pontual L, Cojocaru B, Soussan-Banini V, Craiu I, Skurnik D, Gajdos V, Chéron G, Cohen R, Alberti C, Angoulvant F.

Clin Infect Dis. 2017 Oct 16;65(9):1469-1476. doi: 10.1093/cid/cix590.

PMID:
29048511
4.

Covariate selection for association screening in multiphenotype genetic studies.

Aschard H, Guillemot V, Vilhjalmsson B, Patel CJ, Skurnik D, Ye CJ, Wolpin B, Kraft P, Zaitlen N.

Nat Genet. 2017 Dec;49(12):1789-1795. doi: 10.1038/ng.3975. Epub 2017 Oct 16.

5.

Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Roux D, Weatherholt M, Clark B, Gadjeva M, Renaud D, Scott D, Skurnik D, Priebe GP, Pier G, Gerard C, Yoder-Himes DR.

Infect Immun. 2017 May 23;85(6). pii: e00765-16. doi: 10.1128/IAI.00765-16. Print 2017 Jun.

6.

Evidence for large-scale gene-by-smoking interaction effects on pulmonary function.

Aschard H, Tobin MD, Hancock DB, Skurnik D, Sood A, James A, Vernon Smith A, Manichaikul AW, Campbell A, Prins BP, Hayward C, Loth DW, Porteous DJ, Strachan DP, Zeggini E, O'Connor GT, Brusselle GG, Boezen HM, Schulz H, Deary IJ, Hall IP, Rudan I, Kaprio J, Wilson JF, Wilk JB, Huffman JE, Hua Zhao J, de Jong K, Lyytikäinen LP, Wain LV, Jarvelin MR, Kähönen M, Fornage M, Polasek O, Cassano PA, Barr RG, Rawal R, Harris SE, Gharib SA, Enroth S, Heckbert SR, Lehtimäki T, Gyllensten U; Understanding Society Scientific Group, Jackson VE, Gudnason V, Tang W, Dupuis J, Soler Artigas M, Joshi AD, London SJ, Kraft P.

Int J Epidemiol. 2017 Jun 1;46(3):894-904. doi: 10.1093/ije/dyw318.

7.

Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.

Guillard T, Pons S, Roux D, Pier GB, Skurnik D.

Bioessays. 2016 Jul;38(7):682-93. doi: 10.1002/bies.201500180. Epub 2016 Jun 1. Review.

PMID:
27248008
8.

The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG.

Skurnik D, Cywes-Bentley C, Pier GB.

Expert Rev Vaccines. 2016 Aug;15(8):1041-53. doi: 10.1586/14760584.2016.1159135. Epub 2016 Mar 16. Review.

9.

Fungal microbiota dysbiosis in IBD.

Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Langella P, Skurnik D, Richard ML, Beaugerie L.

Gut. 2017 Jun;66(6):1039-1048. doi: 10.1136/gutjnl-2015-310746. Epub 2016 Feb 3.

10.

Extended-spectrum antibodies protective against carbapenemase-producing Enterobacteriaceae.

Skurnik D, Roux D, Pons S, Guillard T, Lu X, Cywes-Bentley C, Pier GB.

J Antimicrob Chemother. 2016 Apr;71(4):927-35. doi: 10.1093/jac/dkv448. Epub 2016 Jan 7.

11.

Impact of Drug Resistance on Virulence and Fitness of Bacterial Pathogens.

Roux D, Pons S, Guillard T, Ricard JD, Pier GB, Skurnik D.

Crit Care Med. 2016 Jan;44(1):e50. doi: 10.1097/CCM.0000000000001330. No abstract available.

PMID:
26672941
12.

Emergence of Antimicrobial-Resistant Escherichia coli of Animal Origin Spreading in Humans.

Skurnik D, Clermont O, Guillard T, Launay A, Danilchanka O, Pons S, Diancourt L, Lebreton F, Kadlec K, Roux D, Jiang D, Dion S, Aschard H, Denamur M, Cywes-Bentley C, Schwarz S, Tenaillon O, Andremont A, Picard B, Mekalanos J, Brisse S, Denamur E.

Mol Biol Evol. 2016 Apr;33(4):898-914. doi: 10.1093/molbev/msv280. Epub 2015 Nov 26.

13.

Fitness cost of antibiotic susceptibility during bacterial infection.

Roux D, Danilchanka O, Guillard T, Cattoir V, Aschard H, Fu Y, Angoulvant F, Messika J, Ricard JD, Mekalanos JJ, Lory S, Pier GB, Skurnik D.

Sci Transl Med. 2015 Jul 22;7(297):297ra114. doi: 10.1126/scitranslmed.aab1621.

PMID:
26203082
14.

Identification of Poly-N-acetylglucosamine as a Major Polysaccharide Component of the Bacillus subtilis Biofilm Matrix.

Roux D, Cywes-Bentley C, Zhang YF, Pons S, Konkol M, Kearns DB, Little DJ, Howell PL, Skurnik D, Pier GB.

J Biol Chem. 2015 Jul 31;290(31):19261-72. doi: 10.1074/jbc.M115.648709. Epub 2015 Jun 15.

15.

A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.

Lu X, Skurnik D, Pozzi C, Roux D, Cywes-Bentley C, Ritchie JM, Munera D, Gening ML, Tsvetkov YE, Nifantiev NE, Waldor MK, Pier GB.

mBio. 2014 Mar 25;5(2):e00974-14. doi: 10.1128/mBio.00974-14.

16.

Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing.

Skurnik D, Roux D, Cattoir V, Danilchanka O, Lu X, Yoder-Himes DR, Han K, Guillard T, Jiang D, Gaultier C, Guerin F, Aschard H, Leclercq R, Mekalanos JJ, Lory S, Pier GB.

Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20747-52. doi: 10.1073/pnas.1221552110. Epub 2013 Nov 18.

17.

Randomized controlled trial of parent therapeutic education on antibiotics to improve parent satisfaction and attitudes in a pediatric emergency department.

Angoulvant F, Rouault A, Prot-Labarthe S, Boizeau P, Skurnik D, Morin L, Mercier JC, Alberti C, Bourdon O.

PLoS One. 2013 Sep 26;8(9):e75590. doi: 10.1371/journal.pone.0075590. eCollection 2013.

18.

A comprehensive analysis of in vitro and in vivo genetic fitness of Pseudomonas aeruginosa using high-throughput sequencing of transposon libraries.

Skurnik D, Roux D, Aschard H, Cattoir V, Yoder-Himes D, Lory S, Pier GB.

PLoS Pathog. 2013;9(9):e1003582. doi: 10.1371/journal.ppat.1003582. Epub 2013 Sep 5.

19.

Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail.

Roux D, Gaudry S, Khoy-Ear L, Aloulou M, Phillips-Houlbracq M, Bex J, Skurnik D, Denamur E, Monteiro RC, Dreyfuss D, Ricard JD.

Crit Care Med. 2013 Sep;41(9):e191-9. doi: 10.1097/CCM.0b013e31828a25d6.

PMID:
23887232
20.

Commensal Escherichia coli strains in Guiana reveal a high genetic diversity with host-dependant population structure.

Lescat M, Clermont O, Woerther PL, Glodt J, Dion S, Skurnik D, Djossou F, Dupont C, Perroz G, Picard B, Catzeflis F, Andremont A, Denamur E.

Environ Microbiol Rep. 2013 Feb;5(1):49-57. doi: 10.1111/j.1758-2229.2012.00374.x. Epub 2012 Aug 19.

PMID:
23757130
21.

Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens.

Cywes-Bentley C, Skurnik D, Zaidi T, Roux D, Deoliveira RB, Garrett WS, Lu X, O'Malley J, Kinzel K, Zaidi T, Rey A, Perrin C, Fichorova RN, Kayatani AK, Maira-Litràn T, Gening ML, Tsvetkov YE, Nifantiev NE, Bakaletz LO, Pelton SI, Golenbock DT, Pier GB.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):E2209-18. doi: 10.1073/pnas.1303573110. Epub 2013 May 28.

22.

Transcriptional response of mucoid Pseudomonas aeruginosa to human respiratory mucus.

Cattoir V, Narasimhan G, Skurnik D, Aschard H, Roux D, Ramphal R, Jyot J, Lory S.

mBio. 2013 Jan 2;3(6):e00410-12. doi: 10.1128/mBio.00410-12.

23.

Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes.

Roux D, Pier GB, Skurnik D.

J Antimicrob Chemother. 2012 Dec;67(12):2785-7. doi: 10.1093/jac/dks335. Epub 2012 Aug 16. Review.

24.

Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.

Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB.

Clin Infect Dis. 2012 Nov;55(9):1188-97. doi: 10.1093/cid/cis624. Epub 2012 Jul 17.

25.

Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection.

Skurnik D, Davis MR Jr, Benedetti D, Moravec KL, Cywes-Bentley C, Roux D, Traficante DC, Walsh RL, Maira-Litràn T, Cassidy SK, Hermos CR, Martin TR, Thakkallapalli EL, Vargas SO, McAdam AJ, Lieberman TD, Kishony R, Lipuma JJ, Pier GB, Goldberg JB, Priebe GP.

J Infect Dis. 2012 Jun;205(11):1709-18. doi: 10.1093/infdis/jis254. Epub 2012 Mar 23.

26.

Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes.

Lieberman TD, Michel JB, Aingaran M, Potter-Bynoe G, Roux D, Davis MR Jr, Skurnik D, Leiby N, LiPuma JJ, Goldberg JB, McAdam AJ, Priebe GP, Kishony R.

Nat Genet. 2011 Nov 13;43(12):1275-80. doi: 10.1038/ng.997.

27.

Impact of implementing French antibiotic guidelines for acute respiratory-tract infections in a paediatric emergency department, 2005-2009.

Angoulvant F, Skurnik D, Bellanger H, Abdoul H, Bellettre X, Morin L, Aptecar M, Galli-Gibertini G, Bourdon O, Doit C, Faye A, Mercier JC, Cohen R, Alberti C.

Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1295-303. doi: 10.1007/s10096-011-1442-4. Epub 2011 Oct 16.

PMID:
22002230
28.

The decoupling between genetic structure and metabolic phenotypes in Escherichia coli leads to continuous phenotypic diversity.

Sabarly V, Bouvet O, Glodt J, Clermont O, Skurnik D, Diancourt L, de Vienne D, Denamur E, Dillmann C.

J Evol Biol. 2011 Jul;24(7):1559-71. doi: 10.1111/j.1420-9101.2011.02287.x. Epub 2011 May 13.

29.

Biofilm formation by and thermal niche and virulence characteristics of Escherichia spp.

Ingle DJ, Clermont O, Skurnik D, Denamur E, Walk ST, Gordon DM.

Appl Environ Microbiol. 2011 Apr;77(8):2695-700. doi: 10.1128/AEM.02401-10. Epub 2011 Feb 18.

30.

Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.

Skurnik D, Merighi M, Grout M, Gadjeva M, Maira-Litran T, Ericsson M, Goldmann DA, Huang SS, Datta R, Lee JC, Pier GB.

J Clin Invest. 2010 Sep;120(9):3220-33. doi: 10.1172/JCI42748. Epub 2010 Aug 25.

31.

Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population.

Woerther PL, Angebault C, Lescat M, Ruppé E, Skurnik D, Mniai AE, Clermont O, Jacquier H, Costa AD, Renard M, Bettinger RM, Epelboin L, Dupont C, Guillemot D, Rousset F, Arlet G, Denamur E, Djossou F, Andremont A.

J Infect Dis. 2010 Aug 15;202(4):515-23. doi: 10.1086/654883.

PMID:
20617925
32.

Emergence of carbapenem-resistant Hafnia: the fall of the last soldier.

Skurnik D, Nucci A, Ruimy R, Lasocki S, Muller-Serieys C, Montravers P, Andremont A, Courvalin P.

Clin Infect Dis. 2010 May 15;50(10):1429-31. doi: 10.1086/652289. No abstract available.

PMID:
20397936
33.

NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon.

Coant N, Ben Mkaddem S, Pedruzzi E, Guichard C, Tréton X, Ducroc R, Freund JN, Cazals-Hatem D, Bouhnik Y, Woerther PL, Skurnik D, Grodet A, Fay M, Biard D, Lesuffleur T, Deffert C, Moreau R, Groyer A, Krause KH, Daniel F, Ogier-Denis E.

Mol Cell Biol. 2010 Jun;30(11):2636-50. doi: 10.1128/MCB.01194-09. Epub 2010 Mar 29.

34.

Is exposure to mercury a driving force for the carriage of antibiotic resistance genes?

Skurnik D, Ruimy R, Ready D, Ruppe E, Bernède-Bauduin C, Djossou F, Guillemot D, Pier GB, Andremont A.

J Med Microbiol. 2010 Jul;59(Pt 7):804-7. doi: 10.1099/jmm.0.017665-0. Epub 2010 Mar 25.

PMID:
20339018
35.

Antibiotic prophylaxis and recurrent urinary tract infection in children.

Skurnik D, Pier GB, Andremont A.

N Engl J Med. 2010 Feb 11;362(6):555-6; author reply 556-7. No abstract available.

PMID:
20175297
36.

The population genetics of commensal Escherichia coli.

Tenaillon O, Skurnik D, Picard B, Denamur E.

Nat Rev Microbiol. 2010 Mar;8(3):207-17. doi: 10.1038/nrmicro2298. Review.

PMID:
20157339
37.

Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens.

Gening ML, Maira-Litrán T, Kropec A, Skurnik D, Grout M, Tsvetkov YE, Nifantiev NE, Pier GB.

Infect Immun. 2010 Feb;78(2):764-72. doi: 10.1128/IAI.01093-09. Epub 2009 Nov 30.

38.

Organic and conventional fruits and vegetables contain equivalent counts of Gram-negative bacteria expressing resistance to antibacterial agents.

Ruimy R, Brisabois A, Bernede C, Skurnik D, Barnat S, Arlet G, Momcilovic S, Elbaz S, Moury F, Vibet MA, Courvalin P, Guillemot D, Andremont A.

Environ Microbiol. 2010 Mar;12(3):608-15. doi: 10.1111/j.1462-2920.2009.02100.x. Epub 2009 Nov 17.

PMID:
19919536
39.

Development of ertapenem resistance in a patient with mediastinitis caused by Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.

Skurnik D, Lasocki S, Bremont S, Muller-Serieys C, Kitzis MD, Courvalin P, Andremont A, Montravers P.

J Med Microbiol. 2010 Jan;59(Pt 1):115-9. doi: 10.1099/jmm.0.012468-0.

PMID:
19745032
40.

Integrons and antibiotic resistance in phylogenetic group B2 Escherichia coli.

Skurnik D, Lacheeb S, Bernede C, le Menac'h A, Elbaz S, Mohler J, Denamur E, Andremont A, Ruimy R.

Microb Drug Resist. 2009 Sep;15(3):173-8. doi: 10.1089/mdr.2009.0918.

PMID:
19728774
41.

Rapid adaptation of antibiotic therapy for community-acquired peritonitis using direct cultures on antibiotic agar plates: pilot study.

Lasocki S, Skurnik D, Muller-Serieys C, Bronchard R, Marcel C, Marmuse JP, Montravers P, Andremont A.

Surg Infect (Larchmt). 2009 Aug;10(4):333-8. doi: 10.1089/sur.2008.095.

PMID:
19622030
42.

Occurrence of antibiotic resistance and class 1, 2 and 3 integrons in Escherichia coli isolated from a densely populated estuary (Seine, France).

Laroche E, Pawlak B, Berthe T, Skurnik D, Petit F.

FEMS Microbiol Ecol. 2009 Apr;68(1):118-30. doi: 10.1111/j.1574-6941.2009.00655.x. Epub 2009 Feb 19.

43.

Characteristics of human intestinal Escherichia coli with changing environments.

Skurnik D, Bonnet D, Bernède-Bauduin C, Michel R, Guette C, Becker JM, Balaire C, Chau F, Mohler J, Jarlier V, Boutin JP, Moreau B, Guillemot D, Denamur E, Andremont A, Ruimy R.

Environ Microbiol. 2008 Aug;10(8):2132-7. doi: 10.1111/j.1462-2920.2008.01636.x. Epub 2008 May 4.

PMID:
18459976
44.

[Deleterious role of CD16 in sepsis].

Aloulou M, Pinheiro da Silva F, Skurnik D, Benhamou M, Monteiro RC.

Med Sci (Paris). 2008 Mar;24(3):231-3. doi: 10.1051/medsci/2008243231. French. No abstract available.

45.

The amino acid valine is secreted in continuous-flow bacterial biofilms.

Valle J, Da Re S, Schmid S, Skurnik D, D'Ari R, Ghigo JM.

J Bacteriol. 2008 Jan;190(1):264-74. Epub 2007 Nov 2.

46.

CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation.

Pinheiro da Silva F, Aloulou M, Skurnik D, Benhamou M, Andremont A, Velasco IT, Chiamolera M, Verbeek JS, Launay P, Monteiro RC.

Nat Med. 2007 Nov;13(11):1368-74. Epub 2007 Oct 14.

PMID:
17934470
47.

Identification of forces shaping the commensal Escherichia coli genetic structure by comparing animal and human isolates.

Escobar-Páramo P, Le Menac'h A, Le Gall T, Amorin C, Gouriou S, Picard B, Skurnik D, Denamur E.

Environ Microbiol. 2006 Nov;8(11):1975-84.

48.

Effect of human vicinity on antimicrobial resistance and integrons in animal faecal Escherichia coli.

Skurnik D, Ruimy R, Andremont A, Amorin C, Rouquet P, Picard B, Denamur E.

J Antimicrob Chemother. 2006 Jun;57(6):1215-9. Epub 2006 Mar 31.

PMID:
16581916
49.

Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure.

Skurnik D, Le Menac'h A, Zurakowski D, Mazel D, Courvalin P, Denamur E, Andremont A, Ruimy R.

Antimicrob Agents Chemother. 2005 Jul;49(7):3062-5.

50.

Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli.

Denamur E, Tenaillon O, Deschamps C, Skurnik D, Ronco E, Gaillard JL, Picard B, Branger C, Matic I.

Genetics. 2005 Oct;171(2):825-7. Epub 2005 Jun 18.

Supplemental Content

Loading ...
Support Center